Surgery Websites
Thoracic Oncology Program »  Meet the Team »  Radiation Oncologists »  Sue S. Yom, M.D., Ph.D.
Sue S. Yom, M.D., Ph.D.

Sue S. Yom, M.D., Ph.D.

Associate Professor
Department of Radiation Oncology & Otolaryngology, Head and Neck Surgery

Contact Information

Helen Diller Family Comprehensive Cancer Center
1600 Divisadero Street, Box 1708
San Francisco, California 94143-1708
Phone: 415-353-7175
Fax: 415-353-9883
yoms@radonc.ucsf.edu
Open Popup
  • 1987-91, Rice University, Houston, TX,  B.A.  French
  • 1993-02, University of Pennsylvania, Ph.D. English
  • 1995-02, University of Pennsylvania, M.D., Medicine
  • 2002-2003 M.D. Anderson Cancer Center, Intern, Medicine/Surgery
  • 2003-2007 M.D. Anderson Cancer Center, Resident, Radiation Oncology 
  • American Board of Radiology
  • Thoracic Oncology Program
  • Head and Neck Oncology Program
  • Visible Tumor and High-Risk Skin Cancer Program
  • Department of Radiation Oncology
  • Brachytherapy
  • Bronchioloalveolar Carcinoma (BAC)
  • Chemoradiation
  • CyberKnife irradiation for lung and skull base
  • Electron beam and orthovoltage irradiation
  • External-beam radiation therapy
  • Head & Neck Cancer
  • Hyperthemia
  • Intensity-modulated radiation therapy
  • Non-Small Cell Lung Cancer
  • Small-Cell Lung Cancer
  • Advanced imaging and radiation planning
  • Head and neck and lung cancers
  • Image-guided and adaptive radiation therapy
  • Outcomes and quality of life
  • Radiation in combination with chemotherapy and targeted agents
  • Radiation sensitizers and protectors

Dr. Yom is a radiation oncologist who specializes in the treatment of head and neck and lung cancers. She received her M.D. from the University of Pennsylvania in 2002 and completed her residency training at the prestigious M.D. Anderson Cancer Center in Houston, Texas. In 2007, she joined the UCSF faculty as an Assistant Professor of Clinical Radiation Oncology.  

Dr. Yom is particularly interested in emerging radiotherapeutic and biologic techniques aimed at reducing the toxicities of treatment. In head and neck cancer, she has studied a variety of issues related to chemoradiation and combined modality treatments, technical aspects of radiation delivery, and radiation-related prognostic factors and post-treatment management. Specifically in lung cancer, she has been involved in efforts to quantify the risks of pneumonitis and esophagitis resulting from concurrent treatment with chemotherapy and radiation and helped to establish intensity-modulated radiation therapy in the treatment of locoregionally advanced lung cancers.

Evidencing her commitment to patient care and patient-oriented research, Dr. Yom has been the recipient of numerous awards including the ASTRO Fellowship from the Korean American Society for Therapeutic Radiology & Oncology, the Jesse H. Jones Fellowship in Cancer Education for excellence in cancer education at M.D. Anderson Cancer Center, an award from the A. Lavoy Moore Endowment Fund for excellence in lung cancer research, and the Eleanor Montague Distinguished Resident Award in Radiation Oncology from the American Association of Women Radiologists. She has authored numerous peer-reviewed articles and is a regularly invited speaker to fellow professionals in the field.

In lung cancer, Dr. Yom has conducted research quantifying the risks of pneumonitis and esophagitis when chemotherapy and radiation are given simultaneously. Her research findings were important in establishing the early use of intensity-modulated radiation therapy for lung cancer in combination with 4-dimensional CT-based planning. She has particular expertise in the delivery of chemoradiation therapy for advanced-stage lung cancer, and also the delivery of non-invasive stereotactic CyberKnife radiation for early-stage lung cancer. Her hope is that better understanding of radiation toxicities will permit higher treatment doses, increase the rate of cure and improve patient quality of life. She is strongly committed to research that will lead to more effective, less toxic, and more highly individualized therapy for patients.

Dr. Yom is an investigator on many research studies in head and neck and lung cancer at UCSF, including trials related to to image-guided radiation, head and neck patients' quality of life, and combinations of novel systemic agents with radiation therapy. She is especially interested in improved clinical and translational prognostic models in order to provide more effective and individualized therapy. It is hoped that the reduction of toxicities, both through technical and biologic means, will improve patients' quality of life and potentially enable physicians to deliver more intelligently targeted radiation and chemotherapy doses in search of a better chance of cure. She believes in multidisciplinary management and a unified, team-oriented approach to patient care

Most recent publications from a total of 158
  1. Kearney V, Chan JW, Wang T, Perry A, Yom SS, Solberg TD. Attention-enabled 3D boosted convolutional neural networks for semantic CT segmentation using deep supervision. Phys Med Biol. 2019 Jul 02; 64(13):135001. View in PubMed
  2. Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019 Jul 02. View in PubMed
  3. Braverman LC, Yom SS, Zietman AL. Think Carefully, Publish Safely: Co-Authorship and Conflict of Interest Verification in the ASTRO Journals. Int J Radiat Oncol Biol Phys. 2019 Jul 01; 104(3):486-487. View in PubMed
  4. Strohl MP, Chen JP, Ha PK, Seth R, Yom SS, Heaton CM. Can Early Dental Extractions Reduce Delays in Postoperative Radiation for Patients With Advanced Oral Cavity Carcinoma? J Oral Maxillofac Surg. 2019 May 25. View in PubMed
  5. Kallianos KG, Muhoozi BN, Gottschalk A, Yom SS, Chan JW, Henry TS, Elicker BM, Ordovas KG, Naeger DM. Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards. Curr Probl Diagn Radiol. 2019 May 09. View in PubMed
  6. Zietman AL, Yom SS. The Red Journal's Outstanding Reviewers of 2018. Int J Radiat Oncol Biol Phys. 2019 Jul 15; 104(4):703-704. View in PubMed
  7. de Groot PM, Chung JH, Ackman JB, Berry MF, Carter BW, Colletti PM, Hobbs SB, McComb BL, Movsas B, Tong BC, Walker CM, Yom SS, Kanne JP. ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. J Am Coll Radiol. 2019 May; 16(5S):S184-S195. View in PubMed
  8. Gay HA, Santiago R, Gil B, Remedios C, Montes PJ, López-Araujo J, Chévere CM, Imbert WS, White J, Arthur DW, Horton JK, Jagsi R, Rabinovich R, Beriwal S, Viswanathan A, Erickson BA, Rengan R, Palma D, Loo BW, Kavanaugh JA, Bradley J, Yom SS, Harari PM, Lee Burnett O. Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients. Pract Radiat Oncol. 2019 Apr 15. View in PubMed
  9. Chan JW, Kearney V, Haaf S, Wu S, Bogdanov M, Reddick M, Dixit N, Sudhyadhom A, Chen J, Yom SS, Solberg TD. A convolutional neural network algorithm for automatic segmentation of head and neck organs at risk using deep lifelong learning. Med Phys. 2019 May; 46(5):2204-2213. View in PubMed
  10. Yom SS. Integrating the Management of Nodal Metastasis Into the Treatment of Nonmelanoma Skin Cancer. Semin Radiat Oncol. 2019 04; 29(2):171-179. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Sue S. Yom, M.D., Ph.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

Site Directory
    X